ArticleCancers2021

miR-22 Modulates Lenalidomide Activity by Counteracting MYC Addiction in Multiple Myeloma.

Daniele Caracciolo et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.